Related Experiment Video
Updated: Jul 7, 2026

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
Published on: November 3, 2011
SDF-1 recruits cardiac stem cell-like cells that depolarize in vivo
Samuel Unzek1, Ming Zhang, Niladri Mal
1Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Insights
Prolonging SDF-1 expression after myocardial infarction recruits endogenous cardiac myosin stem cells. These cells can depolarize, potentially improving cardiac function without differentiating into mature myocytes.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Stem cell homing to the infarct zone can improve cardiac function.
- Mesenchymal stem cells (MSC) engineered to overexpress SDF-1 reduce cardiac myocyte apoptosis and increase vascular density.
- Previous studies showed no cardiac regeneration from endogenous or infused MSC.
Purpose of the Study:
- To investigate the mechanisms behind improved cardiac function after SDF-1 overexpressing MSC infusion.
- To identify the source and characteristics of cells recruited to the infarct zone.
Main Methods:
- Detailed immunohistochemistry on infarcted myocardium.
- Optical mapping studies to assess cell electrical activity.
- Analysis of connexin expression in recruited cells.
Main Results:
- Overexpression of SDF-1 recruited proliferating cardiac myosin-expressing cells within 2 weeks of acute myocardial infarction (MI).
- These cells did not differentiate into mature cardiac myocytes but were capable of depolarizing.
- Greater optical action potential amplitude was observed in the infarct border of animals receiving SDF-1 overexpressing MSC.
Conclusions:
- Prolonged SDF-1 expression recruits endogenous cardiac myosin stem cells, potentially representing cardiac stem cells.
- These recruited cells contribute to contractile function through depolarization, independent of differentiation.
- The findings suggest a novel mechanism for improving cardiac function post-MI via endogenous stem cell recruitment.
Abstract:
Prolongation or reestablishment of stem cell homing through the expression of SDF-1 in the myocardium has been shown to lead to homing of endothelial progenitor cells to the infarct zone with a subsequent increase in vascular density and cardiac function. While the increase in vascular density is important, there could clearly be other mechanisms involved. In a recent study we demonstrated that the infusion of mesenchymal stem cells (MSC) and MSC that were engineered to overexpress SDF-1 led to significant decreases in cardiac myocyte apoptosis and increases in vascular density and cardiac function compared to control. In that study there was no evidence of cardiac regeneration from either endogenous stem cells or the infused mesenchymal stem cells. In this study we performed further detailed immunohistochemistry on these tissues and demonstrate that the overexpression of SDF-1 in the newly infracted myocardium led to recruitment of small cardiac myosin-expressing cells that had proliferated within 2 weeks of acute MI. These cells did not differentiate into mature cardiac myocytes, at least by 5 weeks after acute MI. However, based on optical mapping studies, these cells appear capable of depolarizing. We observed greater optical action potential amplitude in the infarct border in those animals that received SDF-1 overexpressing MSC than observed in noninfarcted animals and those that received control MSC. Further immunohistochemistry revealed that these proliferated cardiac myosin-positive cells did not express connexin 43, but did express connexin 45. In summary, our study suggests that the prolongation of SDF-1 expression at the time of acute MI leads to the recruitment of endogenous cardiac myosin stem cells that may represent cardiac stem cells. These cells are capable of depolarizing and thus may contribute to increased contractile function even in the absence of maturation into a mature cardiac myocyte.

